Alibaba Health Information Stock Fundamentals
| TWY Stock | EUR 0.44 0.01 2.33% |
Alibaba Health Information fundamentals help investors to digest information that contributes to Alibaba Health's financial success or failures. It also enables traders to predict the movement of Alibaba Stock. The fundamental analysis module provides a way to measure Alibaba Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alibaba Health stock.
Alibaba |
Alibaba Health Information Company Return On Equity Analysis
Alibaba Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Alibaba Health Return On Equity | 0.0088 |
Most of Alibaba Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alibaba Health Information is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Alibaba Health Information has a Return On Equity of 0.0088. This is 100.04% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The return on equity for all Germany stocks is 102.84% lower than that of the firm.
Alibaba Health Infor Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alibaba Health's current stock value. Our valuation model uses many indicators to compare Alibaba Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alibaba Health competition to find correlations between indicators driving Alibaba Health's intrinsic value. More Info.Alibaba Health Information is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alibaba Health's earnings, one of the primary drivers of an investment's value.Alibaba Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alibaba Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alibaba Health could also be used in its relative valuation, which is a method of valuing Alibaba Health by comparing valuation metrics of similar companies.Alibaba Health is rated third in return on equity category among its peers.
Alibaba Fundamentals
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 14.05 B | |||
| Shares Outstanding | 13.52 B | |||
| Shares Owned By Insiders | 64.61 % | |||
| Shares Owned By Institutions | 11.01 % | |||
| Price To Book | 7.98 X | |||
| Price To Sales | 0.56 X | |||
| Revenue | 20.58 B | |||
| Gross Profit | 4.11 B | |||
| EBITDA | (248.7 M) | |||
| Net Income | (265.56 M) | |||
| Book Value Per Share | 1.11 X | |||
| Cash Flow From Operations | 424.36 M | |||
| Number Of Employees | 1.58 K | |||
| Beta | 0.98 | |||
| Market Capitalization | 9.48 B | |||
| Total Asset | 19.2 B | |||
| Z Score | 1.0 | |||
| Net Asset | 19.2 B |
About Alibaba Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alibaba Health Information's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alibaba Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alibaba Health Information based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Alibaba Stock
Alibaba Health financial ratios help investors to determine whether Alibaba Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alibaba with respect to the benefits of owning Alibaba Health security.